The Effect of Hydration on Postprandial Metabolic Responses

February 10, 2025 updated by: Lewis James, Loughborough University

Certain populations, such as industrial workers and endurance athletes are particularly susceptible to dehydration due to exposure to heat for long periods of time causing evaporative water loss via sweating. The physical and cognitive decrements associated with dehydration have been widely researched, however the effect of dehydration on metabolism is lesser known. As climate change is causing temperatures to rise, and metabolic diseases such as type 2 diabetes are more common, the effect of dehydration on metabolism, specifically glycemic response to meals, needs to be established for future recommendations in clinical, environmental and athletic settings.

Therefore, the aim of this study is to investigate the effect of acute exercise-induced dehydration on subsequent metabolic responses to feeding (i.e. glycaemia and insulinaemia).

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Leicestershire
      • Loughborough, Leicestershire, United Kingdom, LE113TU
        • Loughborough University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • Generally fit and healthy
  • Participate in endurance or intermittent exercise at least 3 times a week or minimum of 150 minutes moderate intensity activity per week

Exclusion Criteria:

  • < 18 or > 45
  • Any health condition that may affect study outcomes (e.g., endocrine/liver/renal/cardiovascular disease)
  • Any morbidity that affects ability to cycle
  • Smoker or vaper

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Euhydrated
Light exercise in a hot environment with water ingested to fully replace sweat losses and maintain euhydration.
Water ingested to fully replace sweat losses during exercise.
Experimental: Hypohydrated
Light exercise in a hot environment with water restricted to induce hypohydration of ~3% body mass through sweating.
Water restriction to induce hypohydration of ~3% body mass through sweat losses during exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma glucose
Time Frame: 6 hours
Measured using colorimetric assay from venous blood samples
6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma insulin
Time Frame: 6 hours
Measured using ELISA from venous blood samples
6 hours
Plasma osmolality
Time Frame: 6 hours
Measured using freezing point depression from venous blood samples
6 hours
Plasma volume change
Time Frame: 6 hours
Determined from haemoglobin and haematocrit measures in blood samples collected before and after drink ingestion
6 hours
Urine volume
Time Frame: 6 hours
Determined from urine samples collected before and after exercise
6 hours
Body mass
Time Frame: 6 hours
Determined from weighing participants before and after exercise
6 hours
Urine specific gravity/osmolality
Time Frame: 6 hours
Determined from urine samples collected before and after exercise
6 hours
Thirst sensation
Time Frame: 6 hours
Measured via 100 mm visual analogue scales 0 mm = not at all thirsty 100 mm = extremely thirsty
6 hours
Hunger sensation
Time Frame: 6 hours
Measured via 100 mm visual analogue scales 0 mm = not at all hungry 100 mm = extremely hungry
6 hours
Fullness sensation
Time Frame: 6 hours
Measured via 100 mm visual analogue scales 0 mm = not at all full 100 mm = extremely full
6 hours
Core body temperature
Time Frame: 6 hours
Measured via ingestible pill
6 hours
Blood pressure
Time Frame: 6 hours
Measured via and automated sphygmomanometer
6 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
N-back task for working memory (cognitive function)
Time Frame: 3 hours
The task will comprise three progressively harder memory loads (1-Back, 2-Back, 3-Back). Each stimulus type will be used in all memory loads. Participants will have to respond using the space bar when they see a stimulus that is presented one, two, or three steps previously, dependent on the load condition. Each phase will comprise 50 trials with ten targets presented centrally on a plain white screen. Each stimulus will be presented for 1000 ms unless the participant responds and in which case the next trial will begin. Commission errors and correct responses will be used as indices of performance. Commission errors occur when participants respond to non-targets.
3 hours
Go/no-go task for response inhibition (cognitive function)
Time Frame: 3 hours
Participants will be instructed to press the space bar when an image of a tree appears onscreen ("go" stimulus) and to inhibit responding when an image of a football is presented (the "no-go" stimulus). The task will comprise 200 trials, of which 10% will be no-go trials. Each trial will last 500 ms and will have a black image on a white background. The sequence of stimuli will be the same for each participant. In order to allow for pre-potent tendencies to develop, 50 go trials will precede the first no-go trial. Increased commission error responses (i.e. responding incorrectly on a no-go trial) will indicate reduced response inhibition. Commission errors and correct responses will be measured as indices of performance.
3 hours
Oculomotor function antisaccade task
Time Frame: 3 hours
Each trial will start with a 1-second instruction screen prompting participants to focus on the target. A central fixation point will be displayed for one second, followed by a brief blank interval and then the appearance of a red distractor. The distractor will appear randomly to the left or right of the fixation point and will remain visible for 2 seconds. Participants will be instructed to maintain fixation at the centre and then make a saccade in the opposite direction as soon as the distractor appears. The task will include 24 trials, with four additional practice trials. The primary variables measured will be reaction time mean and standard deviation, which reflect inhibition latency and variability. Antisaccade errors, or the number of incorrect saccades, will also be calculated.
3 hours
Oculomotor function prosaccade task
Time Frame: 3 hours
Each trial will begin with a 1-second instruction screen, followed by a central fixation point and a brief blank interval. A green target then will appear randomly to the left or right of the fixation point for 2 seconds. Participants will be instructed to fixate at the centre and then make a saccade towards the target. The task will include a total of 14 trials, with four additional practice trials. The variables measured will be reaction time mean and standard deviation, which indicate prosaccade latency and variability.
3 hours
Oculomotor function smooth pursuit task
Time Frame: 3 hours
A smooth pursuit task consists of participants following a stimulus with their eyes as it moves in an elliptical pattern on a screen. The stimulus is in motion for 60 seconds. The primary variable measured will be the variability in x and y coordinates of the left and the right eye.
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

February 4, 2025

First Submitted That Met QC Criteria

February 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 10, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-20370

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycaemia

Clinical Trials on Water intake

Subscribe